Christopher Morton

Chief Executive Officer, ELEM Biotech

Specialising in emerging technology ventures and markets, Chris worked across mechanical industries (aero, auto, energy) before turning to health tech 5 years ago. With ELEM, Chris and his Co-Founder work to deliver the most powerful and safe environment for medical trials by modelling humans on supercomputers.

Prior to ELEM, Chris held executive roles at Atos and Sogeti HighTech (CapGemini), set up Altair France, founded and led Samtech UK until its acquisition by LMS, now Siemens. Chris has an international background, read Aeronautical Engineering at Imperial College and Business Studies at Hult IBS. He enjoys sports, finance, and politics and took a special interest in Grow Movement and mental health.